Literature DB >> 500187

Influence of preformed antibody on experimental Streptococcus sanguis endocarditis.

W M Scheld, J H Thomas, M A Sande.   

Abstract

The influence of preformed, anti-whole organism antibody on the development of Streptococcus sanguis endocarditis was examined in both in vivo and in vitro systems. Antibody prevented, rather than potentiated, endocarditis in rabbits. The infectious dose in 30 control animals was 10(6.5) +/- 0.33 (mean +/- standard deviation); this increased to 10(7.71 +/- 0.05 in 36 immunized animals (P less than 0.01). No differences in bacterial clearance mechanisms were apparent between groups. Antibody also prevented the adherence of S. sanguis to the constituents of nonbacterial thrombotic endocarditis (fibrin and platelets) in vitro. When preincubated in high-titer antisera, adherence of S. sanguis was reduced compared with controls (adherence ratio mean +/- standard error of the mean, X 10(4): 174 +/- 5 versus 427 +/- 10, P less than 0.001). Preadsorption of immune sera with intact S. sanguis restored adherence to normal values, whereas preadsorption with dextran was partially effective. These studies demonstrate that preformed antibody had a protective role in vivo and suggest that a possible mechanism is blockade of adherence, a crucial early step in the pathogenesis of endocarditis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500187      PMCID: PMC414515          DOI: 10.1128/iai.25.3.781-785.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in Irus monkeys (Macaca fascicularis).

Authors:  R T Evans; F G Emmings; R J Genco
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

2.  An immunofluorescent method for detecting antibodies against viridans streptococci in Streptococcus viridans endocarditis.

Authors:  D C Shanson; C Hince
Journal:  J Clin Pathol       Date:  1978-03       Impact factor: 3.411

3.  Immunoglobulin responses to bacterial endocarditis.

Authors:  J S Lunn; P A Bunn
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

4.  An immunological investigation into the prevention of caries in deciduous teeth of rhesus monkeys.

Authors:  T Lehner; S J Challacombe; J Caldwell
Journal:  Arch Oral Biol       Date:  1975 May-Jun       Impact factor: 2.633

5.  Dextran production as a possible virulence factor in streptococcal endocarditis.

Authors:  L L Pelletier; M Coyle; R Petersdorf
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

6.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis.

Authors:  D T Durack; B C Gilliland; R G Petersdorf
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

8.  Circulating immune complexes in infective endocarditis.

Authors:  A S Bayer; A N Theofilopoulos; R Eisenberg; F J Dixon; L B Guze
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

9.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

10.  Adherence of glucan-positive and glucan-negative streptococcal strains to normal and damaged heart valves.

Authors:  C H Ramirez-Ronda
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  15 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Authors:  H B Viscount; C L Munro; D Burnette-Curley; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.

Authors:  Stefano Mancini; Carmen Menzi; Frank Oechslin; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Analysis of cross-protection between serotypes and passively transferred immune globulin in experimental nutritionally variant streptococcal endocarditis.

Authors:  I van de Rijn
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 5.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

6.  Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

Authors:  W M Scheld; R A Calderone; J P Brodeur; M A Sande
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Role of culture conditions and immunization in experimental nutritionally variant streptococcal endocarditis.

Authors:  I van de Rijn
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Role of granulocytes in experimental Streptococcus sanguis endocarditis.

Authors:  M J Meddens; J Thompson; F Eulderink; W C Bauer; H Mattie; R van Furth
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits.

Authors:  D P Greenberg; J I Ward; A S Bayer
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

10.  Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits.

Authors:  W M Scheld; O Zak; K Vosbeck; M A Sande
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.